OncoSil Medical Ltd (AU:OSL) has released an update.
OncoSil Medical Ltd has announced the issue of 66.2 million unquoted options set to expire on June 30, 2025, at an exercise price of $0.009 each, effective July 3, 2024. These securities are not intended for quotation on the ASX and are part of a transaction previously disclosed in an Appendix 3B.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.
